iBIO Announces Keynote Speakers for 2011 iBIO IndEx
CHICAGO--(BUSINESS WIRE)--Jan 17, 2011 - The Illinois Biotechnology Industry Organization (iBIO®) today announced its preliminary lineup of keynote speakers for the 2011 iBIO Industry Exposition (iBIO IndEx). Archer Daniel Midland Company's Mark Matlock, senior vice president, Food Research; and Hospira, Inc.'s Sumant Ramachandra, M.D., Ph.D., senior vice president, R&D, Medical & Regulatory Affairs and chief scientific officer, will address approximately 500 life sciences professionals during the 2011 iBIO IndEx, February 15 & 16 at the Hyatt Regency Hotel in Chicago.
Mr. Matlock will review agricultural biotechnology's contributions to increasing food availability and discuss its potential for future improvements in nutrition quality for both humans and livestock, including the development of new food ingredients that can satisfy consumers' tastes while also improving their health.
Dr. Ramachandra will address Hospira's progress on innovation and sustainable growth since its spinoff from Abbott, which includes a company-wide transformation effort called Project Fuel, as well as advancing the company's leadership in biosimilars and innovative products.
“iBIO is proud to present two of the Midwest's leading business executives to the hundreds of professionals attending the 2011 iBIO IndEx,” said David Miller, iBIO president and chief executive officer. “Sumant and Mark—through their management of breakthrough health care and food products—exemplify the deep level of forward-looking expertise resident in our biotechnology community.”
The theme of this year's iBIO IndEx, is “Achieving Sustainability.” David Miller will deliver a “State of the Community” address to review our recent progress and detail the challenges confronting us at the state, regional and national levels. Mr. Miller will lay out practical steps needed to repair the state's business climate, foster an innovation-based economy and solve America's severe math and science educational crisis.
In addition to the keynote presentations and the “State of the Community” address, other 2011 iBIO IndEx highlights include:
- Business partnering program
- Panel presentations and workshops
- Extensive networking opportunities
- PROPEL® Business Plan Competition ($10,000 cash award)
For more information on the 2011 iBIO IndEx, PROPEL Business Plan Competition (application deadline is January 18), sponsorship packages and registration, visit www.ibio.org/ibioindex.
The Illinois Biotechnology Industry Organization (iBIO) champions biotechnology in Illinois and the surrounding Midwest region. Headquartered in Chicago, iBIO's mission is to strengthen the leadership position of Illinois and the Midwest as a globally recognized center of medical, agricultural and industrial biotechnology. With leaders from business, academia and government, iBIO promotes the development and retention of new companies as well as corporate expansions. iBIO advocates for sensible public policy at the local, state and federal levels. To learn more about iBIO and its programs, visit www.ibio.org.
iBIO's Leadership Sponsors are Abbott, Astellas Pharma US, Baxter International Inc. and Takeda Pharmaceuticals North America.
Posted: January 2011